The Splenic Microenvironment Is a Novel Site of Relapse Following ABT-199 Treatment

被引：0
|
作者：
Di Grande, Alessandra [1 ]
Piers, Sofie [2 ]
Van Vlierberghe, Pieter [2 ]
Chonghaile, Triona Ni [1 ]
机构：
[1] Royal Coll Surgeons Ireland, Physiol & Med Phys, Dublin, Ireland
[2] Univ Ghent, Dept Biomol Med, Ghent, Belgium
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127970
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3800
引用
收藏
页数：2
相关论文
共 43 条
  • [41] Low Incidence of Tumor Lysis Syndromes (TLS) and Infusion Related Reactions (IRR) in the CLL2-Bag Trial Evaluating a Sequential Treatment of Bendamustine (B), Obinutuzumab (GA101, G) and Venetoclax (ABT-199, A) in Patients with Chronic Lymphocytic Leukemia (CLL): Interim Safety Results of a Phase-II-Trial of the German CLL Study Group (GCLLSG)
    Cramer, Paula
    von Tresckow, Julia
    Bahlo, Jasmin
    Robrecht, Sandra
    Engelke, Anja
    Langerbeins, Petra
    Fink, Anna-Maria
    Balke-Want, Hyatt
    Al-Sawaf, Othman
    Seiler, Till
    von Weikersthal, Ludwig Fischer
    Hebart, Holger
    Fischer, Kirsten
    Wendtner, Clemens-Martin
    Stilgenbauer, Stephan
    Eichhorst, Barbara F.
    Hallek, Michael
    BLOOD, 2016, 128 (22)
  • [42] Hematologic improvement following treatment with TLK199 (a novel glutathione analog inhibitor of GST p1-1) in myelodysplastic syndrome (MDS): Interim results of a phase 1-2a study.
    Faderl, S
    Kantarjian, H
    Estey, E
    Verstovsek, S
    Garcia-Manero, G
    Kwari, M
    Callander, N
    Eimanuel, P
    Piro, L
    Keck, J
    Jameson, A
    Patel, K
    Brown, GL
    Estrov, Z
    BLOOD, 2003, 102 (11) : 426A - 426A
  • [43] Hematologic improvement following treatment with TLK199 (Telintra™), a novel glutathione analog inhibitor of GST P1-1, in myelodysplastic syndrome (MDS):: Interim results of a dose-ranging phase 2a study.
    Callander, N
    Ochoa-Bayona, JL
    Piro, L
    Guba, S
    Shapiro, G
    Williams, S
    Oliff, I
    Burris, H
    Jameson, A
    Patel, K
    Brown, GL
    Faderl, S
    Estrov, Z
    Emanuel, P
    BLOOD, 2004, 104 (11) : 400A - 400A
12345